Bessler Robert's Form 4 filing
LifeStance Health Group, Inc.LFST · filed Apr 27, 2026
- Accession no.
- 0001193125-26-182153
- Filed
- Apr 27, 2026
- Trade date
- Apr 23-24, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions. Open-market sales total $492.4K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bessler RobertCIK 0001864881 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | Common Stock | SSaleDisposed | −3,876 | $7.00F1 | −$27,132 | 1,305,521 | Indirect | |
| Apr 23, 2026 | Common Stock | SSaleDisposed | −3,876 | $7.00F1 | −$27,132 | 1,422,320 | Indirect | |
| Apr 24, 2026 | Common Stock | SSaleDisposed | −31,073 | $7.05F4 | −$219,064.65 | 1,274,448 | Indirect | |
| Apr 24, 2026 | Common Stock | SSaleDisposed | −31,074 | $7.05F4 | −$219,071.7 | 1,391,246 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.00 to $7.005 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Referenced by the price of 2 transactions in Table I.
- F4
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.00 to $7.095 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Referenced by the price of 2 transactions in Table I.